New Results
Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
Mirjana Efremova, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Dietmar Rieder, Hubert Hackl, Natascha Hermann-Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam, Zlatko Trajanoski
doi: https://doi.org/10.1101/099747
Mirjana Efremova
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Victoria Klepsch
2Division of Translational Cell Genetics, Medical University of Innsbruck, Innsbruck, Austria
Pornpimol Charoentong
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Francesca Finotello
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Dietmar Rieder
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Hubert Hackl
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Natascha Hermann-Kleiter
2Division of Translational Cell Genetics, Medical University of Innsbruck, Innsbruck, Austria
Martin Löwer
3TRON–Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany
Gottfried Baier
2Division of Translational Cell Genetics, Medical University of Innsbruck, Innsbruck, Austria
Anne Krogsdam
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Zlatko Trajanoski
1Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
Article usage
Posted June 19, 2017.
Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
Mirjana Efremova, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Dietmar Rieder, Hubert Hackl, Natascha Hermann-Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam, Zlatko Trajanoski
bioRxiv 099747; doi: https://doi.org/10.1101/099747
Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
Mirjana Efremova, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Dietmar Rieder, Hubert Hackl, Natascha Hermann-Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam, Zlatko Trajanoski
bioRxiv 099747; doi: https://doi.org/10.1101/099747
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8722)
- Bioinformatics (29127)
- Biophysics (14932)
- Cancer Biology (12048)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12220)
- Genomics (16766)
- Immunology (11841)
- Microbiology (28005)
- Molecular Biology (11552)
- Neuroscience (60808)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4939)
- Plant Biology (10384)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)